GeneDx Holdings Corp. (WGS) Current Ratio
- Current ratio · latest quarter: Value 3.30×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 3.30× | Current assets / current liabilities. $246.36M ÷ $74.63M ≈ 3.30× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 246.36M USD | Assets, Current |
| Current obligations | 74.63M USD | Liabilities, Current |
| Cash and equivalents | 60.32M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 72.23M USD | Marketable Securities, Current |
| Customer receivables | 83.61M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 17.82M USD | Inventory, Net |
| Payables | 5.15M USD | Accounts Payable, Current |
| Borrowing debt due within one year | 0.00 USD | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $246.36M | $74.63M | $60.32M | $72.23M | $83.61M | $17.82M | $5.15M | $0.00 | 3.30× |
| 2026-03-31 | $270.63M | $87.64M | $93.92M | $76.76M | $76.93M | $12.24M | $11.17M | $0.00 | 3.09× |
| 2025-12-31 | $268.29M | $108.91M | $105.00M | $66.28M | $74.37M | $13.95M | $2.46M | $4.54M | 2.46× |
| 2025-09-30 | $237.58M | $87.62M | $95.97M | $59.11M | $60.94M | $10.57M | $2.63M | $1.23M | 2.71× |
| 2025-06-30 | $204.84M | $71.41M | $74.12M | $60.44M | $48.03M | $11.93M | $3.52M | $1.22M | 2.87× |
| 2025-03-31 | $225.82M | $69.54M | $99.70M | $59.46M | $45.98M | $12.66M | $15.86M | $1.22M | 3.25× |
| 2024-12-31 | $197.97M | $54.82M | $85.21M | $55.97M | $37.63M | $10.65M | $7.95M | $1.21M | 3.61× |
| 2024-09-30 | $186.01M | $77.34M | $57.89M | $58.57M | (m) | $10.77M | $9.02M | $1.21M | 2.41× |
| 2024-06-30 | $162.17M | $68.27M | $56.08M | $50.78M | (m) | $10.32M | $8.13M | $1.10M | 2.38× |
| 2024-03-31 | $163.42M | $50.73M | $83.67M | $29.24M | (m) | $11.62M | $9.48M | $798.00K | 3.22× |
| 2023-12-31 | $182.34M | $58.82M | $99.68M | $30.47M | (m) | $8.78M | $10.24M | (m) | 3.10× |
| 2023-09-30 | $171.81M | $68.37M | $87.39M | $26.91M | (m) | $9.35M | $15.37M | $198.00K | 2.51× |
| 2023-06-30 | $213.28M | $84.37M | $156.66M | (m) | (m) | $11.53M | $25.01M | $0.00 | 2.53× |
| 2023-03-31 | $272.35M | $119.03M | $201.90M | (m) | $32.91M | $12.33M | $36.92M | $0.00 | 2.29× |
| 2022-12-31 | $212.62M | $144.30M | $123.93M | $0.00 | (m) | $13.66M | $46.02M | $4.75M | 1.47× |
| 2022-09-30 | $306.61M | $162.33M | $191.36M | (m) | $42.67M | $44.17M | $40.12M | $349.00K | 1.89× |
| 2022-06-30 | $402.70M | $204.61M | $284.65M | (m) | $45.80M | $41.60M | $53.30M | $0.00 | 1.97× |
| 2022-03-31 | $410.42M | $100.64M | $315.00M | (m) | $37.64M | $36.32M | (m) | $0.00 | 4.08× |
| 2021-12-31 | $483.54M | $101.28M | $400.57M | (m) | $26.51M | $33.46M | $44.69M | $0.00 | 4.77× |
| 2021-09-30 | $538.51M | $71.61M | $461.28M | (m) | $21.26M | $31.17M | $43.32M | (m) | 7.52× |
| 2021-06-30 | $99.01M | $72.61M | $26.50M | (m) | $24.57M | $29.13M | $45.23M | (m) | 1.36× |
| 2021-03-31 | $140.24M | $68.70M | $58.65M | (m) | $33.34M | $32.97M | $42.10M | (m) | 2.04× |
| 2020-12-31 | $174.11M | $73.44M | $108.13M | (m) | $32.04M | $24.96M | $26.74M | $1.77M | 2.37× |
| 2020-09-30 | $1.47M | $44.35K | $1.14M | (m) | (m) | (m) | (m) | (m) | 33.04× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |